Keyphrases
Myelodysplastic Syndrome
89%
Clonal Hematopoiesis
60%
Acute Myeloid Leukemia
48%
Confidence Interval
35%
Myeloproliferative Neoplasms
32%
SNP Array
31%
Post-transplantation Cyclophosphamide (PTCy)
30%
Metaphase Cytogenetics
29%
Myelodysplastic
23%
Relapse-free Survival
21%
Myeloid Malignancies
20%
Overall Survival
19%
Graft-versus-host Disease (GvHD)
19%
Allogeneic Blood or Marrow Transplantation
16%
Acute Lymphoblastic Leukemia
14%
Hematopoietic Cell Transplantation
14%
Allogeneic Transplantation
14%
Hypomethylating Agents
14%
Genomic Landscape
14%
Hedgehog
14%
Neoplasms
14%
ASXL1
13%
Leukemia
13%
Myelodysplastic Syndrome/myeloproliferative Neoplasm
12%
Minimal Residual Disease
12%
Clonality
12%
Array-based
12%
Recurrent mutation
11%
All-cause Mortality
11%
Epigenetic Modification
11%
Dasatinib
11%
Enhancer of Zeste Homolog 2 (EZH2)
10%
SETBP1
10%
Hematological Malignancies
10%
Secondary Acute Myeloid Leukemia (sAML)
10%
Leukemia Patients
10%
Somatic mutation
10%
Peripheral Blood
10%
Myeloablative Conditioning
10%
Transplant Outcomes
10%
Immunodominant
9%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
9%
Overlap Syndrome
9%
Isocitrate Dehydrogenase 1 (IDH1)
9%
Chromosomal Disorders
9%
Del(20q)
9%
Allogeneic Bone Marrow Transplantation
9%
Hazard Ratio
9%
Complementarity-determining Region 3 (CDR3)
9%
Blood or Marrow Transplantation
9%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Single-Nucleotide Polymorphism
69%
Cytogenetics
60%
Metaphase
49%
Karyotyping
47%
Uniparental Disomy
38%
Hematopoiesis
34%
SNP Array
20%
Somatic Mutation
19%
Bone Marrow Failure
16%
Epigenetics
16%
Stem Cell
15%
Cell Transplantation
14%
Reprogramming
14%
Cytotoxic T Cell
14%
Clonal Variation
13%
Clonality
12%
All Cause Mortality
12%
Genetics
11%
Single Nucleotide Polymorphism
11%
ASXL1
11%
Chromosomal Abnormalities
10%
Methylation
10%
RUNX1
10%
EZH2
10%
KMT2A
9%
Precursor
9%
Progenitor Cell
9%
Missense
9%
Loss of Heterozygosity
9%
T Cell Receptor
9%
Monosomy
8%
SF3B1
8%
DNA Methylation
8%
T Cell
8%
Allele
7%
Hedgehog
7%
Fluorescence in Situ Hybridization
7%
Promoter Region
7%
Antineoplastic Activity
7%
Hematopoietic Stem Cell
7%
Chromosome Arm
7%
Serine
7%
Cell Clone
7%
Philadelphia Chromosome
7%
Gene Frequency
7%
Germ Cell
7%
Germline
7%
Mitochondrial DNA
7%
Cardiovascular Mortality
7%
Medicine and Dentistry
Hematopoiesis
83%
Myelodysplastic Syndrome
58%
Acute Myeloid Leukemia
49%
Hematopoietic Stem Cell
27%
Disease
26%
Overall Survival
25%
Myeloproliferative Neoplasm
25%
Transplantation
24%
Cyclophosphamide
22%
Cell Transplantation
19%
Hazard Ratio
18%
Bone Marrow Failure
16%
Myeloid Malignancy
16%
Recurrence Free Survival
15%
Minimal Residual Disease
14%
Somatic Mutation
14%
Diagnosis
12%
Hematopoietic Stem Cell
12%
Hematologic Malignancy
11%
Leukemia
11%
ASXL1
10%
Neoplasm
9%
Prevalence
9%
Cancer
9%
Morphology
9%
Overlap Syndrome
9%
Marrow Failure Syndrome
9%
Graft Versus Host Reaction
9%
Precursor
8%
Drug Megadose
8%
Prophylaxis
8%
Myeloid Leukemia
7%
Atherosclerosis
7%
Janus Kinase
7%
Antineoplastic Activity
7%
Neutrophilia
7%
Chemokine Receptor
7%
FMS-Like Tyrosine Kinase 3
7%
Sickle-Cell Disease
7%
Hypomethylating Agent
7%
Cell-Free DNA
7%
Allotransplantation
7%
Cytotoxic T-Cell
7%
Tagraxofusp
7%
Myelofibrosis
7%
T-Cell Response
7%
Promoter Region
7%
Aplastic Anemia
7%
Acute Lymphoblastic Leukemia
7%
All Cause Mortality
7%